Camphor, lidocaine, and methyl salicylate topical and Ibritumomab
Determining the interaction of Camphor, lidocaine, and methyl salicylate topical and Ibritumomab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: camphor / lidocaine / methyl salicylate topical
Brand name: JointFlex, Original Ointment, Viva
Synonyms: Camphor, lidocaine, and methyl salicylate (topical)
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camphor, lidocaine, and methyl salicylate topical-Ibritumomab Intravenous
- Camphor, lidocaine, and methyl salicylate topical-Ibritumomab Tiuxetan
- Camphor, lidocaine, and methyl salicylate topical-Ibrutinib
- Camphor, lidocaine, and methyl salicylate topical-Ibrutinib Capsules
- Camphor, lidocaine, and methyl salicylate topical-Ibrutinib Tablets
- Camphor, lidocaine, and methyl salicylate topical-Ibu
- Ibritumomab-Camptosar
- Ibritumomab-Camrese
- Ibritumomab-Camrese extended-cycle
- Ibritumomab-Camrese Lo
- Ibritumomab-Camrese Lo extended-cycle
- Ibritumomab-Canagliflozin